Janney Montgomery Scott LLC acquired a new stake in Amdocs Limited (NASDAQ:DOX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 4,109 shares of the technology company's stock, valued at approximately $350,000.
A number of other institutional investors have also recently made changes to their positions in the company. Liberty One Investment Management LLC lifted its position in shares of Amdocs by 2.5% during the 4th quarter. Liberty One Investment Management LLC now owns 211,443 shares of the technology company's stock valued at $18,002,000 after buying an additional 5,252 shares during the last quarter. HB Wealth Management LLC lifted its position in shares of Amdocs by 7.4% during the 4th quarter. HB Wealth Management LLC now owns 3,839 shares of the technology company's stock valued at $327,000 after buying an additional 264 shares during the last quarter. Wedge Capital Management L L P NC lifted its holdings in Amdocs by 15.1% during the 4th quarter. Wedge Capital Management L L P NC now owns 818,021 shares of the technology company's stock worth $69,646,000 after purchasing an additional 107,349 shares in the last quarter. Steph & Co. lifted its holdings in Amdocs by 14.4% during the 4th quarter. Steph & Co. now owns 6,649 shares of the technology company's stock worth $566,000 after purchasing an additional 837 shares in the last quarter. Finally, Fulton Bank N.A. lifted its holdings in Amdocs by 11.1% during the 4th quarter. Fulton Bank N.A. now owns 4,482 shares of the technology company's stock worth $382,000 after purchasing an additional 449 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.
Analyst Ratings Changes
DOX has been the topic of a number of recent research reports. Barclays dropped their price objective on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. StockNews.com raised Amdocs from a "buy" rating to a "strong-buy" rating in a report on Wednesday, February 5th. Finally, Oppenheimer increased their price objective on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $101.20.
Read Our Latest Analysis on DOX
Amdocs Price Performance
Shares of DOX traded up $1.07 during trading hours on Friday, reaching $88.30. 663,595 shares of the company's stock traded hands, compared to its average volume of 648,680. The stock has a market cap of $9.97 billion, a PE ratio of 20.49, a price-to-earnings-growth ratio of 1.41 and a beta of 0.71. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The firm's 50 day simple moving average is $85.86 and its 200-day simple moving average is $86.48. Amdocs Limited has a 12 month low of $74.41 and a 12 month high of $94.04.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. Equities analysts expect that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Sunday, April 20th. Stockholders of record on Monday, March 31st will be given a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.39%. The ex-dividend date is Monday, March 31st. This is an increase from Amdocs's previous quarterly dividend of $0.48. Amdocs's dividend payout ratio (DPR) is 44.55%.
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
